Suppr超能文献

化疗和靶向药物肾毒性的管理:2020年

Management of nephrotoxicity of chemotherapy and targeted agents: 2020.

作者信息

Chiruvella Varsha, Annamaraju Pavan, Guddati Achuta K

机构信息

Division of Hematology/Oncology, Georgia Cancer Center, Augusta University Augusta, GA 30909, USA.

Department of Medicine, Liberty University College of Medicine Lynchburg, VA, USA.

出版信息

Am J Cancer Res. 2020 Dec 1;10(12):4151-4164. eCollection 2020.

Abstract

Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has been well documented and these effects are carefully managed by oncologists during their usage. The introduction of targeted agents has added a new challenge to cancer management as their nephrotoxic effects and associated management is in the process of being adopted by oncologists. This work is a compilation of side effects on the renal system due to various chemotherapeutic, immunotherapeutic and targeted agents followed by their recommended management.

摘要

某些化疗药物(如顺铂和异环磷酰胺)的肾毒性作用已有充分记录,肿瘤学家在使用这些药物时会谨慎处理这些影响。靶向药物的引入给癌症治疗带来了新的挑战,因为它们的肾毒性作用及相关处理方法正处于被肿瘤学家采用的过程中。这项工作汇编了各种化疗药物、免疫治疗药物和靶向药物对肾脏系统的副作用及其推荐的处理方法。

相似文献

6
Nephrotoxicity of anticancer treatment.抗肿瘤治疗的肾毒性。
Nephrol Dial Transplant. 2017 Jun 1;32(6):924-936. doi: 10.1093/ndt/gfw338.

引用本文的文献

1
B-Mode Ultrasound May Be an Early Marker in Acute Kidney Injury.B超可能是急性肾损伤的早期标志物。
Diagnostics (Basel). 2025 Aug 14;15(16):2034. doi: 10.3390/diagnostics15162034.

本文引用的文献

2
Nephrotoxicity in cancer treatment: An overview.癌症治疗中的肾毒性:概述
World J Clin Oncol. 2020 Apr 24;11(4):190-204. doi: 10.5306/wjco.v11.i4.190.
3
Eculizumab in chemotherapy-induced thrombotic microangiopathy.依库珠单抗治疗化疗诱导的血栓性微血管病。
Clin Nephrol Case Stud. 2020 Apr 17;8:25-32. doi: 10.5414/CNCS109836. eCollection 2020.
5
Hyponatremia in patients with cancer.癌症患者的低钠血症。
Curr Opin Nephrol Hypertens. 2019 Sep;28(5):433-440. doi: 10.1097/MNH.0000000000000525.
6
Thrombotic Microangiopathy in Cancer.癌症相关血栓性微血管病。
Semin Thromb Hemost. 2019 Jun;45(4):348-353. doi: 10.1055/s-0039-1687893. Epub 2019 Apr 30.
10
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy.嵌合抗原受体 T 细胞治疗相关细胞因子释放综合征。
Biol Blood Marrow Transplant. 2019 Apr;25(4):e123-e127. doi: 10.1016/j.bbmt.2018.12.756. Epub 2018 Dec 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验